Garzotto M - Search Results

1

Unconventional Bladder Preservation: Factors Predicting Failure to Receive Definitive Surgery following Chemotherapy for Nonmetastatic Muscle Invasive Bladder Cancer in the National Cancer Database.

Kapadia AA, Martinez Acevedo A, Liu JJ, Garzotto M, Conlin M, Amling C, Kopp RP. Kapadia AA, et al. Among authors: garzotto m. J Urol. 2018 Sep;200(3):535-540. doi: 10.1016/j.juro.2018.03.075. Epub 2018 Mar 15. J Urol. 2018. PMID: 29551404

2

Combined androgen deprivation with radiotherapy for prostate cancer: does it make sense?

Garzotto M. Garzotto M. Mol Urol. 2000 Fall;4(3):209-13;discussion 215. Mol Urol. 2000. PMID: 11062376 Review.

3

Phase II study of abarelix depot for androgen independent prostate cancer progression during gonadotropin-releasing hormone agonist therapy.

Beer TM, Garzotto M, Eilers KM, Lemmon D. Beer TM, et al. Among authors: garzotto m. J Urol. 2003 May;169(5):1738-41. doi: 10.1097/01.ju.0000059584.47272.9d. J Urol. 2003. PMID: 12686821 Clinical Trial.

4

Targeting FSH in androgen-independent prostate cancer: abarelix for prostate cancer progressing after orchiectomy.

Beer TM, Garzotto M, Eilers KM, Lemmon D, Wersinger EM. Beer TM, et al. Among authors: garzotto m. Urology. 2004 Feb;63(2):342-7. doi: 10.1016/j.urology.2003.09.045. Urology. 2004. PMID: 14972486

5

Imatinib mesylate and zoledronic acid in androgen-independent prostate cancer.

Tiffany NM, Wersinger EM, Garzotto M, Beer TM. Tiffany NM, et al. Among authors: garzotto m. Urology. 2004 May;63(5):934-9. doi: 10.1016/j.urology.2003.12.022. Urology. 2004. PMID: 15134984 Clinical Trial.

6

Radical retropubic prostatectomy after orthotopic liver transplantation.

Bayne A, Barry JM, Garzotto M. Bayne A, et al. Among authors: garzotto m. Urology. 2005 Jan;65(1):175. doi: 10.1016/j.urology.2004.08.008. Urology. 2005. PMID: 15667896

7

Prostate-specific antigen decline after gonadotropin-releasing hormone antagonist withdrawal in androgen-independent prostate cancer.

Wagner M, Garzotto M, Lemmon D, Eilers KM, Beer TM. Wagner M, et al. Among authors: garzotto m. Urology. 2005 Apr;65(4):799. doi: 10.1016/j.urology.2004.10.059. Urology. 2005. PMID: 15833548

8

High dose pulse calcitriol, docetaxel and estramustine for androgen independent prostate cancer: a phase I/II study.

Tiffany NM, Ryan CW, Garzotto M, Wersinger EM, Beer TM. Tiffany NM, et al. Among authors: garzotto m. J Urol. 2005 Sep;174(3):888-92. doi: 10.1097/01.ju.0000169261.42298.e6. J Urol. 2005. PMID: 16093981 Clinical Trial.

9

Testosterone loss and estradiol administration modify memory in men.

Beer TM, Bland LB, Bussiere JR, Neiss MB, Wersinger EM, Garzotto M, Ryan CW, Janowsky JS. Beer TM, et al. Among authors: garzotto m. J Urol. 2006 Jan;175(1):130-5. doi: 10.1016/S0022-5347(05)00049-2. J Urol. 2006. PMID: 16406889

10

Classification and regression tree analysis for the prediction of aggressive prostate cancer on biopsy.

Spurgeon SE, Hsieh YC, Rivadinera A, Beer TM, Mori M, Garzotto M. Spurgeon SE, et al. Among authors: garzotto m. J Urol. 2006 Mar;175(3 Pt 1):918-22. doi: 10.1016/S0022-5347(05)00353-8. J Urol. 2006. PMID: 16469580

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

115 results

Search Page

Filters